Skip to main content

STAAR Surgical Company

corporate_fare Company Profile

STAAR Surgical Company

STAA·NASDAQ·Industrial Applications And Services·CIK 0000718937

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems. The company is a leading manufacturer of phakic implantable lenses used globally in corrective or "refractive" surgery, with over 40 years dedicated to ophthalmic surgery. STAAR generates worldwide revenue almost exclusively from sales of its Implantable Collamer Lenses, or "ICLs." These ICLs are made from Collamer, a proprietary collagen copolymer material created and exclusively used by STAAR, making the lenses soft, flexible, and biocompatible with the eye. ICLs are phakic lenses, implanted into the eye without removing the natural crystalline lens, distinguishing them from other refractive procedures that involve corneal tissue removal. All ICLs are foldable, allowing for insertion through a small incision during minimally invasive surgery. While intended to be permanent, STAAR's ICLs are reversible lens implants. The company markets and sells its "EVO" family of lenses for refractive surgery to treat myopia (nearsightedness), which includes the EVO ICL, EVO+ ICL, and EVO Visian ICL. The newest offering, EVO Viva, features an extended depth of focus (EDoF) optic designed to treat myopia with presbyopia (age-related loss of ability to focus). STAAR also markets and sells an ICL lens called Visian ICL to treat hyperopia (farsightedness).

STAAR Surgical Company (NASDAQ:STAA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 29 items for STAA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for STAA spans 10-Q, 8-K, DEF 14A, SCHEDULE 13D/A.

Recent high-impact activity:

  • STAAR Q3: Sales Down 12% Reported, Up 21% Ex-China Timing; Margin Falls to 70.9%
  • Q3 Sales Fall 12% but Underlying Growth Hits 21%; Margins Squeezed
  • STAAR Surgical Announces $50M Share Buyback, Stock Surges
  • STAAR Surgical Q2 Sales Hit $93.5M, Swings to Profit on China Surge
  • STAAR Surgical Q2 2026: Net Income $8.1M, China Sales Surge 888%

Financial Snapshot

Fiscal year ended January 2, 2026
Revenue
$239.44M
Net Income
-$80.45M
Diluted EPS
-$1.62
Op. Cash Flow
-$34.23M
Free Cash Flow
-$40.05M
Gross Profit
$182.42M
Operating Income
-$91.71M
Cash & Equivalents
$153.15M
Debt / Equity
0.00×
Net Margin
-33.6%
Shares Outstanding
49.4M sh
Source: 10-K · filed 2026-03-03 · accession 0000718937-26-000004

Short Interest & Short Volume

6.76 days to cover

FINRA reported short interest of 3,649,950 shares in STAA as of the October 30, 2026 settlement, a 1.2% decrease from the prior period — about 6.8 days to cover at its recent average daily volume. On November 20, 2026, 36.1% of STAA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)3,649,950 shares as of October 30, 2026
Change vs prior period▼ 1.2%
Days to cover6.76 at avg daily volume of 540,263
Daily short volume (FINRA facilities)36.1% of 159,210 shares on November 20, 2026
5-day average short volume36.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with S →
$24.22
52-week range · as of 2026-11-04 $15.59 – $35.87
Market cap
$1.22B
Volume
585.6K (0.8× avg)
3-mo avg 708.8K
Live data · 2026-11-22 09:01 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed STAA - Latest Insights

STAA
Nov 04, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $27.17
Real-time Price: $24.22 info
Change: -$2.95 (-11%) info
Market Cap: $1.216B info
STAA
Nov 04, 2026, 4:01 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $27.22
Real-time Price: $24.22 info
Change: -$3.00 (-11%) info
Market Cap: $1.216B info
STAA
Sep 25, 2026, 11:49 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $20.28
Real-time Price: $24.22 info
Change: +$3.94 (+19%) info
Market Cap: $1.216B info
STAA
Aug 12, 2026, 4:11 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $22.92
Real-time Price: $24.22 info
Change: +$1.30 (+6%) info
Market Cap: $1.216B info
STAA
Aug 12, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $24.40
Real-time Price: $24.22 info
Change: -$0.180 (-0.74%) info
Market Cap: $1.216B info
STAA
Aug 06, 2026, 11:04 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.89
Real-time Price: $24.22 info
Change: +$1.33 (+6%) info
Market Cap: $1.216B info
STAA
Jul 16, 2026, 6:04 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $25.59
Real-time Price: $24.22 info
Change: -$1.37 (-5%) info
Market Cap: $1.216B info
STAA
Jul 16, 2026, 4:01 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $28.98
Real-time Price: $24.22 info
Change: -$4.76 (-16%) info
Market Cap: $1.216B info
STAA
Jun 22, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $28.83
Real-time Price: $24.22 info
Change: -$4.61 (-16%) info
Market Cap: $1.216B info
STAA
May 13, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $34.68
Real-time Price: $24.22 info
Change: -$10.46 (-30%) info
Market Cap: $1.216B info
STAA
May 13, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $32.14
Real-time Price: $24.22 info
Change: -$7.92 (-25%) info
Market Cap: $1.216B info
STAA
May 13, 2026, 4:01 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $31.00
Real-time Price: $24.22 info
Change: -$6.78 (-22%) info
Market Cap: $1.216B info
STAA
May 04, 2026, 4:01 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $27.29
Real-time Price: $24.22 info
Change: -$3.07 (-11%) info
Market Cap: $1.216B info
STAA
Apr 08, 2026, 4:06 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $24.47
Real-time Price: $24.22 info
Change: -$0.250 (-1%) info
Market Cap: $1.216B info
STAA
Apr 08, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $25.53
Real-time Price: $24.22 info
Change: -$1.31 (-5%) info
Market Cap: $1.216B info
STAA
Mar 13, 2026, 9:29 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $18.84
Real-time Price: $24.22 info
Change: +$5.38 (+29%) info
Market Cap: $1.216B info
STAA
Mar 13, 2026, 7:59 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $18.84
Real-time Price: $24.22 info
Change: +$5.38 (+29%) info
Market Cap: $1.216B info
STAA
Mar 03, 2026, 4:05 PM EST
Source: Wiseek News
Importance Score:
9
Price at Filing: $17.49
Real-time Price: $24.22 info
Change: +$6.73 (+38%) info
Market Cap: $1.216B info
STAA
Mar 03, 2026, 3:58 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $17.10
Real-time Price: $24.22 info
Change: +$7.12 (+42%) info
Market Cap: $1.216B info
STAA
Feb 05, 2026, 8:06 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $17.54
Real-time Price: $24.22 info
Change: +$6.68 (+38%) info
Market Cap: $1.216B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets